Clinical Trial Update: Budesonide for Induction of Remission in Incomplete Microscopic Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating budesonide for induction of remission in incomplete microscopic colitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incomplete Microscopic Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Incomplete Microscopic Colitis | Phase 3 | Status: COMPLETED